000			02182 a2200601 4500
005			20250517024356.0
264		0	_c20150904
008			201509s 0 0 eng d
022			_a1468-3296
024	7		_a10.1136/thoraxjnl-2014-206670 _2doi
040			_aNLM _beng _cNLM
100	1		_aFrith, Peter A
245	0	0	_aGlycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study, a randomised controlled trial. _h[electronic resource]
260			_bThorax _cJun 2015
300			_a519-27 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Inhalation
650	0	4	_aAged
650	0	4	_aAlbuterol _xanalogs & derivatives
650	0	4	_aAndrostadienes _xtherapeutic use
650	0	4	_aAustralia
650	0	4	_aBronchodilator Agents _xtherapeutic use
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aFluticasone
650	0	4	_aForced Expiratory Volume _xdrug effects
650	0	4	_aGlycopyrrolate _xtherapeutic use
650	0	4	_aHealth Status
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNew Zealand
650	0	4	_aPulmonary Disease, Chronic Obstructive _xdiagnosis
650	0	4	_aRisk Factors
650	0	4	_aSalmeterol Xinafoate
650	0	4	_aScopolamine Derivatives _xtherapeutic use
650	0	4	_aSeverity of Illness Index
650	0	4	_aSurveys and Questionnaires
650	0	4	_aTiotropium Bromide
650	0	4	_aTreatment Outcome
700	1		_aThompson, Philip J
700	1		_aRatnavadivel, Rajeev
700	1		_aChang, Catherina L
700	1		_aBremner, Peter
700	1		_aDay, Peter
700	1		_aFrenzel, Christina
700	1		_aKurstjens, Nicol
773	0		_tThorax _gvol. 70 _gno. 6 _gp. 519-27
856	4	0	_uhttps://doi.org/10.1136/thoraxjnl-2014-206670 _zAvailable from publisher's website
999			_c24773093 _d24773093